Detailseite
Projekt Druckansicht

Typ 1 Diabetes: Einfluss extrazellulärer Matrix auf immun-vermittelte Zerstörung der pankreatischen Inseln

Antragstellerin Dr. Nadine Nagy
Fachliche Zuordnung Endokrinologie, Diabetologie, Metabolismus
Förderung Förderung von 2011 bis 2014
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 213790947
 
Erstellungsjahr 2015

Zusammenfassung der Projektergebnisse

We recently reported that abundant deposits of the extracellular matrix polysaccharide hyaluronan (HA) characterize autoimmune insulitis in human type 1 diabetes (T1D) but the significance of these deposits was unclear. Here, we demonstrate that HA is critical for the pathogenesis of autoimmune diabetes. Using the DO11.10xRIPmOVA (DORmO) mouse model of T1D, we show that HA deposits are temporally and anatomically associated with the development of insulitis. Moreover, treatment with an inhibitor of HA synthesis, 4-methylumbelliferone (4-MU), halted progression to diabetes even after the onset of insulitis. 4- MU reduced HA accumulation, constrained effector T-cells to non-destructive insulitis, and increased numbers of intra-islet Foxp3+ regulatory T-cells (Treg). Consistent with this, Treg differentiation was inhibited by HA and anti-CD44 antibodies and rescued by 4-MU in an ERK1/2-dependent manner. These data may explain how peripheral immune tolerance is impaired in tissues under autoimmune attack, including islets in T1D. We propose that 4-MU, already an approved drug used to treat biliary spasm, could be repurposed to prevent, and possibly treat, T1D in at-risk individuals.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung